Abstract
Since proteins and peptides play critical roles in many biological phenomena, their use as drugs is of great interest. However, their development is limited due to their poor bioavailability, antigenicity and unfavorable pharmacokinetics. In the majority of cases, not all domains of proteins are essential protein-protein interactions necessary for biological activities but only small regions of their folded structure, perform the interactions. Usually, these particular secondary structures are β-turns, occurring on the exposed surface of proteins, constitute the functional elements involved in molecular recognition processes between proteins, and in interactions between ligands and receptors. Moreover, there are also several examples of the design of modified peptides as therapeutic agents by mimicking β-turn structures. In view of this, this review will be focused on the importance of β-turn in some biological phenomena, such as prohormone proteolytic processing. This report will also address the use of β-turn mimicking strategies and its application in the design of potent peptide analogues which play an equally important role. Due to the optimal surface conformation, β-turn mimetics lead to productive interaction with receptors and antibodies.
Keywords: β-Turn, secondary structure, receptor, analog, posttranslational modification, prohormone convertases, precursor, substrate dynamics
Central Nervous System Agents in Medicinal Chemistry
Title: Functional Role of β-Turn in Polypeptide Structure and its use as Template to Design Therapeutic Agents
Volume: 6 Issue: 3
Author(s): Noureddine Brakch, Boutaina El Abida and Mohamed Rholam
Affiliation:
Keywords: β-Turn, secondary structure, receptor, analog, posttranslational modification, prohormone convertases, precursor, substrate dynamics
Abstract: Since proteins and peptides play critical roles in many biological phenomena, their use as drugs is of great interest. However, their development is limited due to their poor bioavailability, antigenicity and unfavorable pharmacokinetics. In the majority of cases, not all domains of proteins are essential protein-protein interactions necessary for biological activities but only small regions of their folded structure, perform the interactions. Usually, these particular secondary structures are β-turns, occurring on the exposed surface of proteins, constitute the functional elements involved in molecular recognition processes between proteins, and in interactions between ligands and receptors. Moreover, there are also several examples of the design of modified peptides as therapeutic agents by mimicking β-turn structures. In view of this, this review will be focused on the importance of β-turn in some biological phenomena, such as prohormone proteolytic processing. This report will also address the use of β-turn mimicking strategies and its application in the design of potent peptide analogues which play an equally important role. Due to the optimal surface conformation, β-turn mimetics lead to productive interaction with receptors and antibodies.
Export Options
About this article
Cite this article as:
Brakch Noureddine, El Abida Boutaina and Rholam Mohamed, Functional Role of β-Turn in Polypeptide Structure and its use as Template to Design Therapeutic Agents, Central Nervous System Agents in Medicinal Chemistry 2006; 6 (3) . https://dx.doi.org/10.2174/187152406778226707
DOI https://dx.doi.org/10.2174/187152406778226707 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Male Pelvic Pain: Beyond Urology and Chronic Prostatitis
Current Rheumatology Reviews Neurotrophins Role in Depression Neurobiology: A Review of Basic and Clinical Evidence
Current Neuropharmacology Synthesis and Pharmacological Studies of Novel 3-Substituted Indole Derivatives as Potential Anti-Inflammatory and Analgesic Agents
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) WNT Signaling in Stem Cell Biology and Regenerative Medicine
Current Drug Targets HPLC-MS Determination and Pharmacokinetic Study of 7, 8- Dihydroxyflavone, a Naturally-Occurring Neuroprotective Agent after a Single Oral Administration in Rats
Current Pharmaceutical Analysis Commentary: Research Highlights: IKKβ Mediates Aβ-Triggered Microglial Inflammation and Neuronal Death During Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Group I Metabotropic Glutamate Receptors: Involvement in Drug-Seeking and Drug-Induced Plasticity
Current Molecular Pharmacology GABAB Receptors as Potential Therapeutic Targets
Current Drug Targets - CNS & Neurological Disorders Preparation and Thermal Analysis of Flame-retardant Chitosan Thin Films on Ammonium Polyphosphate Treated Reconstituted Tobacco Sheet
Current Analytical Chemistry The Effect of a Spiritual Care on Hope in Patients Undergoing Hemodialysis: A Randomized Controlled Trial
Current Psychiatry Research and Reviews The Role of Xanthine Oxidase Inhibitors in Patients with History of Stroke: A Systematic Review
Current Vascular Pharmacology Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?
Current Vascular Pharmacology Reactive Oxygen Species Formation by Polymorphonuclear Cells and Mononuclear Cells as a Risk Factor of Cardiovascular Diseases
Current Pharmaceutical Biotechnology A High Accumulation of Hair Minerals in Mongolian People: 2nd Report; Influence of Manganese, Iron, Lead, Cadmium and Aluminum to Oxidative Stress, Parkinsonism and Arthritis
Current Aging Science The Potential of Pregabalin in Neurology, Psychiatry and Addiction: A Qualitative Overview
Current Pharmaceutical Design Peptide Agonists and Antagonists with Potential Application in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) The Kinetic Component in Drug Discovery: Using the Most Basic Pharmacological Concepts to Advance in Selecting Drugs to Combat CNS Diseases
Current Neuropharmacology Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Current Molecular Medicine A Glance on the Role of Bacterial Siderophore from the Perspectives of Medical and Biotechnological Approaches
Current Drug Targets GABAA Receptors, Anesthetics and Anticonvulsants in Brain Development
CNS & Neurological Disorders - Drug Targets